University of Texas's MD Anderson Cancer Center: Dual-Targeting CAR NK Cells Can Prevent Cell Dysfunction And Tumor Escape
September 30, 2022
September 30, 2022
HOUSTON, Texas, Sept. 30 (TNSjou) -- The University of Texas's MD Anderson Cancer Center issued the following news release on Sept. 29, 2022:
* * *
Preclinical study suggest novel engineering approach could enhance CAR NK activity
* * *
Researchers at The University of Texas MD Anderson Cancer Center have developed a new approach to engineering natural killer (NK) cells with a second chimeric antigen receptor (CAR) to act as a logic gate, . . .
* * *
Preclinical study suggest novel engineering approach could enhance CAR NK activity
* * *
Researchers at The University of Texas MD Anderson Cancer Center have developed a new approach to engineering natural killer (NK) cells with a second chimeric antigen receptor (CAR) to act as a logic gate, . . .